|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TRANSLATIONAL PHYSIOLOGY
1Alberta Diabetes Institute, University of Alberta, Edmonton; and 2Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
Submitted 13 November 2008 ; accepted in final form 22 March 2009
β-Guanadinopropionic acid (β-GPA) feeding leads to reductions in skeletal muscle phosphagen concentrations and has been used as a tool with which to study the effects of energy charge on skeletal muscle metabolism. Supplementing standard rodent diets with β-GPA leads to increases in mitochondrial enzyme content in fast but not slow-twitch muscles from male rats. Given this apparent discrepancy between muscle types we used β-GPA feeding as a model to study signaling pathways involved in mitochondrial biogenesis. We hypothesized that β-GPA feeding would result in a preferential activation of p38 MAPK and AMPK signaling and reductions in RIP140 protein content in triceps but not soleus muscle. Despite similar reductions in high-energy phosphate concentrations, 6 wk of β-GPA feeding led to increases in mitochondrial proteins in triceps but not soleus muscles. Differences in the response of mitochondrial proteins to β-GPA feeding did not seem to be related to a differential activation of p38 MAPK and AMPK signaling pathways or discrepancies in the induction of PPAR
coactivator (PGC)-1
and -1β. The protein content and expression of the nuclear corepressor RIP140 was reduced in triceps but not soleus muscle. Collectively our results indicate that chronic reductions in high-energy phosphates lead to the activation of p38 MAPK and AMPK signaling and increases in the expression of PGC-1
and -1β in both soleus and triceps muscles. The lack of an effect of β-GPA feeding on mitochondrial proteins in the soleus muscles could be related to a fiber type-specific effect of β-GPA on RIP140 protein content.
β-guanadinopropionic acid; peroxisome proliferator-activated receptor-
coactivator-1
; skeletal muscle; rat; kinase; RIP140
This article has been cited by other articles:
![]() |
R. K. Chaturvedi, N. Y. Calingasan, L. Yang, T. Hennessey, A. Johri, and M. F. Beal Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation Hum. Mol. Genet., August 15, 2010; 19(16): 3190 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Frier, D. B. Williams, and D. C. Wright The effects of apelin treatment on skeletal muscle mitochondrial content Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1761 - R1768. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |